Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2021		40,531,996
Beginning balance at Mar. 31, 2021	$ (25,055)	$ 4	$ 144,201	$ (168,403)	$ (857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	31,925	31,925
Stock options exercised	$ 134		134
Restricted stock units vested (in shares)		12,750
Issuance of common stock (Note 10) (in shares)		9,370,251
Issuance of common stock (Note 10)	50,273	$ 1	50,272
Conversion of promissory note (Note 10) (in shares)		3,120,000
Conversion of promissory note (Note 10)	14,378		14,378
Stock-based compensation	1,856		1,856
Other comprehensive loss	(131)				(131)
Net loss	(5,236)			(5,236)
Ending balance (in shares) at Dec. 31, 2021		53,066,922
Ending balance at Dec. 31, 2021	36,219	$ 5	210,841	(173,639)	(988)
Beginning balance (in shares) at Sep. 30, 2021		41,664,020
Beginning balance at Sep. 30, 2021	$ (19,546)	$ 4	150,843	(169,475)	(918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	0
Restricted stock units vested (in shares)		9,750
Issuance of common stock (Note 10) (in shares)		8,273,152
Issuance of common stock (Note 10)	$ 44,773	$ 1	44,772
Conversion of promissory note (Note 10) (in shares)		3,120,000
Conversion of promissory note (Note 10)	14,378		14,378
Stock-based compensation	848		848
Other comprehensive loss	(70)				(70)
Net loss	(4,164)			(4,164)
Ending balance (in shares) at Dec. 31, 2021		53,066,922
Ending balance at Dec. 31, 2021	$ 36,219	$ 5	210,841	(173,639)	(988)
Beginning balance (in shares) at Mar. 31, 2022	53,379,307	53,379,307
Beginning balance at Mar. 31, 2022	$ 31,361	$ 5	211,190	(178,638)	(1,196)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	168,326	168,326
Stock options exercised	$ 709		709
Restricted stock units vested (in shares)		115,731
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability (in shares)		(1,620)
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability	(6)		(6)
Issuance of common stock (Note 10) (in shares)		3,199,999
Issuance of common stock (Note 10)	15,720	$ 1	15,719
Stock-based compensation	2,342		2,342
Other comprehensive loss	(136)				(136)
Net loss	$ (21,808)			(21,808)
Ending balance (in shares) at Dec. 31, 2022	56,861,743	56,861,743
Ending balance at Dec. 31, 2022	$ 28,182	$ 6	229,954	(200,446)	(1,332)
Beginning balance (in shares) at Sep. 30, 2022		56,626,340
Beginning balance at Sep. 30, 2022	$ 36,345	$ 6	228,178	(189,986)	(1,853)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	154,904	154,904
Stock options exercised	$ 653		653
Restricted stock units vested (in shares)		80,551
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability (in shares)		(52)
Stock-based compensation	1,123		1,123
Other comprehensive loss	521				521
Net loss	$ (10,460)			(10,460)
Ending balance (in shares) at Dec. 31, 2022	56,861,743	56,861,743
Ending balance at Dec. 31, 2022	$ 28,182	$ 6	$ 229,954	$ (200,446)	$ (1,332)